SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-043861
Filing Date
2022-08-02
Accepted
2022-08-02 16:18:36
Documents
2
Period of Report
2022-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1534
2 POA DOCUMENT poa.txt EX-24 4298
  Complete submission text file 0001209191-22-043861.txt   7215
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4747 EXECUTIVE DRIVE SUITE 1150 SAN DIEGO CA 92121
Business Address
Bessen Laura (Reporting) CIK: 0001926815 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39567 | Film No.: 221128963